Only a few studies have systemically analyzed the association between neonatal jaundice and childhood-onset allergic diseases. Methods: From 2000 to 2007, 27,693 neonates with newly diagnosed neonatal jaundice and 55,367 matched nonneonatal jaundice cohorts were identified. The incidences and hazard ratios (HRs) of five allergic diseases, namely allergic conjunctivitis (AC), allergic rhinitis (AR), atopic dermatitis (AD), asthma, and urticaria, by the end of 2008 were calculated. results: The incidence density and HRs of the five allergic diseases were greater in the neonatal jaundice cohort than in the nonneonatal jaundice cohort, and the HRs declined modestly with age. The HRs for AR (HR = 2.51, 95% confidence interval (CI) = 2.43-2.59) and AD (HR = 2.51, 95% CI = 2.40-2.62) were the highest, and that for urticaria was the lowest (HR = 2.06, 95% CI = 1.94-2.19). The HRs of allergic diseases were substantially greater for boys and those requiring phototherapy. The HRs of the allergic diseases, except urticaria (HR = 2.49, 95% CI = 1.57-3.97), were not significantly different between the neonatal jaundice regardless of whether the patients received exchange transfusion. conclusion: Neonatal jaundice is associated with the development of allergic diseases in early childhood.
n eonatal jaundice results from a predisposition to the production of bilirubin in newborn infants, especially preterm infants, and their limited ability to excrete it. Infants have higher rates of bilirubin production because they have red blood cells with a higher turnover and a shorter life span, and they have a limited ability to excrete it because of the reduced activity of glucuronyl transferase, which converts bilirubin into water-soluble bilirubin glucuronides (1, 2) . When the concentration of serum bilirubin exceeds its protein binding capacity, bilirubin crystals aggregate and precipitate in neurons (1, 2) . In the past decades, phototherapy and exchange transfusion have been widely used to prevent hyperbilirubinemia-induced neurological damage (3, 4) . Bilirubin, a powerful antioxidant, may be distributed to other tissues (5) (6) (7) . In addition, bilirubin has been found to have immunomodulatory effects, inhibiting the T helper-1 (Th1) cell response and interleukin-2 (IL-2) production (8) . A reduction in the level of IL-2 skews the Th1/ Th2 balance toward Th2, thereby increasing the risk of atopy development (9, 10) . Although previous studies have reported the relationship of neonatal jaundice with childhood asthma, few studies have systemically analyzed the association between neonatal jaundice and common childhood allergic diseases (11) (12) (13) (14) (15) . The prevalence of allergic diseases has risen dramatically worldwide, creating a health care burden. Identifying the pathologic agents and risk factors of allergic diseases may facilitate disease prevention and more specific treatment. Therefore, there is great interest in studying the long-term effects of bilirubin on the development of atopic diathesis. Allergic conjunctivitis (AC), allergic rhinitis (AR), atopic dermatitis (AD), asthma, and urticaria are common organ-specific childhood allergic diseases (10) . Hence, we conducted a nationwide birth cohort study to systemically investigate the incidence and relative risk of common allergic diseases in children with neonatal jaundice. We hypothesized that bilirubin would increase the future risk of atopic diathesis.
RESULTS
The baseline demographic and clinical characteristics of the sample are presented in Table 1 . Among the two cohorts, of which one comprised children with neonatal jaundice and one comprised nonneonatal jaundice controls, 60.2% were boys. The neonatal jaundice cohort was significantly more likely than the nonneonatal jaundice cohort to have fetal and newborn respiratory conditions (6.3 vs. 1.6%), infections (14.6 vs. 2.0%), preterm delivery and low birth weight (9.3 vs. 1.7%), other birth conditions (8.6 vs. 1.7%), and glucose-6-phosphate dehydrogenase deficiency (1.2 vs. 0.1%). These perinatal conditions were confounding factors and were adjusted later to study the association between allergic diseases and neonatal jaundice.
In all age groups, the incidences of all allergic diseases were higher for the neonatal jaundice cohort than for the nonneonatal jaundice cohort ( Table 2) . The HRs for AR (HR = 2.51, 95% confidence interval (CI) = 2.43-2.59) and AD (HR = 2.51, 95% CI = 2.40-2.62) were the highest, and that for urticaria was the lowest (HR = 2.06, 95% CI = 1.94-2.19). Differences in the disease type-specific incidence were greatest for AR (68 per 1,000 person-years for the neonatal jaundice cohort vs. 26 per 1,000 person-years for the nonneonatal jaundice cohort), whereas the smallest difference was noted for urticaria (13 per 1,000 person-years for the neonatal jaundice cohort vs. 6 per 1,000 person-years for the nonneonatal jaundice cohort). The incidences of all allergic diseases and sex-specific adjusted HRs were higher in boys in both cohorts.
The Kaplan-Meier plots in Figure 1 show the 9-y probabilities of developing AC, AR, AD, asthma, and urticaria. The cumulative incidence of each allergic disease was higher for the neonatal jaundice cohort than for the nonneonatal jaundice cohort (log-rank test, P < 0.001). The difference in cumulative incidences between the two cohorts was the greatest for AR and the smallest for urticaria.
Phototherapy was significantly associated with a higher risk of allergic diseases (Table 3) , and exchange transfusion was significantly associated with a higher risk of urticaria (adjusted HR = 2.52, 95% CI = 1.59-4.02) ( Table 4) . By 6 y of age, the children in both cohorts had higher incidence rates for all allergic diseases, and the children in the neonatal jaundice cohort had higher adjusted HRs for most of the allergic diseases except for AR ( Table 5 ). We further investigated the incidence rates and hazard ratios (HRs) of allergic diseases in children with or without neonatal jaundice stratified by full term, birth weight <1,000 g, and birth weight 1,000-2,499 g. Increased HRs for the five allergic diseases were consistently found in the three stratified groups ( Table 6) .
DISCUSSION
This population-based cohort study investigated the incidences and relative risks of five allergic diseases in children with neonatal jaundice in comparison with those without neonatal jaundice. The results consistently show higher risks of allergic diseases in childhood among those with neonatal jaundice. Furthermore, these risks were associated with a high bilirubin level requiring phototherapy.
Four previous studies have reported the association between neonatal jaundice and asthma (11) (12) (13) (14) . Two studies in Sweden conducted by Aspberg et al. first reported the association of neonatal jaundice and phototherapy with childhood asthma requiring hospitalization (odds ratio = 1.27, 95% CI = 1.08, 1.50) and confirmed that neonatal jaundice and phototherapy are associated with the use of antiasthmatic drugs before 12 y of age (odds ratio = 1.30, 95% CI = 1.16, 1.47) in their subsequent analysis (11, 12) . In another birth cohort study performed in the United States during 1959−1965, when phototherapy was unavailable, neonatal hyperbilirubinemia was associated with an increased risk of childhood asthma (odds ratio = 1.61, 95% CI = 1.04, 2.08) (14) . In the current study, the HRs of the five allergic diseases were consistently higher in the neonatal jaundice cohort than in the nonneonatal jaundice cohort when they were stratified by full term and low birth weight. A strong association between preterm delivery and the diagnosis of asthma has been reported (16, 17) . In the current study, we found that the incidence rates of asthma were the highest in children with a birth weight <1,000 g in both cohorts. However, the HRs of asthma were the lowest in the children with a birth weight <1,000 g. These findings are in line with those of previous studies. Two recent Taiwanese studies showed an association between neonatal jaundice and asthma (13) (odds ratio = 1.64, 95% CI = 1.36, 1.98) as well as AR (15) (odds ratio = 1.46, 95% CI = 1.24, 1.72). However, these two studies used the claims data of a sample of one million patients from the National Health Insurance Research Database (NHIRD), thus limiting the number of study patients and resulting in a loss of statistical significance for other atopic diseases. Moreover, no previous studies have analyzed as many allergic diseases as the current study did. This study is the first to report the risks of each allergic disease (AC, AR, AD, asthma, and urticaria) in children with neonatal jaundice and that phototherapy was associated with increased risks , adjusted for age, sex and comorbidities of fetal and newborn respiratory conditions, infections, preterm, low birth weight, other birth conditions, and Glucose-6-phosphate dehydrogenase (G6PD) deficiency. *P < 0.05, **P < 0.001. Articles Wei et al.
of these diseases. These associations were consistent among all five diseases regardless of age and sex. The incidence rate for AR was the highest, with an overall incidence density rate of 68 per 1,000 person-years in the neonatal jaundice cohort, representing a 2.4-fold increase over the incidence rate for AC and a 5.2-fold increase over the incidence rate for urticaria. , adjusted for age, sex and comorbidities of fetal and newborn respiratory conditions, infections, preterm, low birth weight, other birth conditions, and Glucose-6-phosphate dehydrogenase (G6PD) deficiency. *P < 0.05, **P < 0.001. , adjusted for age, sex, and comorbidities of fetal and newborn respiratory conditions, infections, preterm, low birth weight, other birth conditions, and Glucose-6-phosphate dehydrogenase (G6PD) deficiency. Follow time was divided into before school-age (≤6 y) and school age (>6 y). *P < 0.05, **P < 0.001.
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Sex-specific relative hazards were higher among boys for all allergic diseases, indicating that the impact of neonatal jaundice is greater among boys than among girls. The age-specific relative hazards were higher in children ≤6 y, indicating that neonatal jaundice is associated with the development of allergic diseases since early childhood. The discrepancy between sex and age groups has not been well documented in previous studies.
With the increasing prevalence of allergic diseases worldwide, much interest has been focused on studying the effects of environmental stimuli on the early development of the immune system. Being a noninvasive method and as effective as exchange transfusion in preventing bilirubin encephalopathy, phototherapy had been widely applied to treat neonatal jaundice for many decades. However, recent evidence has revealed that phototherapy may affect the Th2/Th1 switch, which contributes to the development of allergic diseases. First, phototherapy may alter the Th2/Th1 cytokine profile, increasing the levels of tumor necrosis factor-α, IL-1-β, and IL-8 and a reducing the level of IL-6 in newborn infants (18, 19) . Second, phototherapy causing DNA damage to lymphocytes can affect the genes regulating the Th2/Th1 switch (20, 21) . Third, UV light, despite being a small component of phototherapy, can activate the inflammatory pathways, leading to allergic diseases or autoimmune disorders (22) . Fourth, a proper increase in the level of unconjugated bilirubin inhibits complement activation, prevents leukocyte migration, and protects infants from oxidative stress (23) . This evidence supports our findings that interfering with physiological bilirubin metabolism by administering neonatal phototherapy may be a risk factor for allergic diseases in later life.
Exchange transfusion was a common procedure for treating extremely severe hyperbilirubinemia in neonates until the National Institute of Child Health and Human Development reported that phototherapy was as effective as exchange transfusion in preventing bilirubin encephalopathy in 1985 (24, 25) . Since then, phototherapy has been widely adopted as the primary therapy for neonatal jaundice. Only one study has described increased levels of serum immunoglobulin E (IgE) in infants after exchange transfusion for neonatal jaundice (26) . However, the long-term effects of exchange transfusion on atopy in infants with neonatal jaundice remain unclear. The results of the current study, investigating for the first time the association between exchange transfusion and a long-term risk of allergic diseases, showed that only urticaria had a significant association with exchange transfusion, while it had the weakest association with phototherapy compared with other allergic diseases. The mean time from the diagnosis of neonatal Because only a few studies are reported in literatures and few patients required exchange transfusion in the current study, further study is warranted to elucidate the association between exchange transfusion and atopy as well as the mechanisms underlying this association. The mechanisms underlying the effects of neonatal jaundice on allergic diseases remain unclear. Previous studies have suggested that bilirubin may inhibit the Th1 cell response, and intracellular accumulation of unconjugated bilirubin may inhibit the production of IL-2 (8, 18, 19) . A reduction in the level of IL-2 skews the Th1/Th2 balance toward Th2, thereby increasing the risk of developing allergic diseases (9,10). Glutathione S-transferases are a large family of proteins that participate in the metabolism of reactive oxygen species and detoxification of xenobiotics. Polymorphisms in the genes of glutathione S-transferase indicate an association between neonatal hyperbilirubinemia and allergy, asthma, and AD (27) (28) (29) (30) . Bilirubin may increase intestinal protein permeability and may be associated with a higher risk of developing an allergy to cow milk protein in young infants (31) . Our findings suggest that atopy is not a disease of a single organ, but rather a systemic response to common pathophysiology consequences. These allergic diseases may progress over time and may occur concurrently. The pathophysiologic complexity of the relationship between neonatal jaundice and allergic consequences warrants further exploration.
The strengths of this study are as follows. First, we employed a large population-based dataset to quantify the atopic risk in children with neonatal jaundice and used a retrospective cohort design, which may minimize the selection bias observed in previous case-control studies (11, 12) . In 1995, Taiwan launched a national health insurance (NHI) program operated by a single buyer, the government. Medical reimbursement specialists and peer reviewers scrutinize all insurance claims. The diagnoses of diseases (including the five allergic diseases and neonatal jaundice) for variables and comorbidities in the NHIRD were based on the ICD-9-CM codes, which were strictly determined by related specialists and physicians according to the standard clinical diagnosis criteria. Therefore, the diagnoses and codes for the variables and comorbidities used in this study should be correct and reliable. Second, we analyzed the effects of several common allergic diseases. Third, the neonatal jaundice and nonneonatal jaundice cohorts were established by matching the patients according to sex and other sociodemographic factors to control for confounding factors. Fourth, we adjusted for numerous perinatal events (including fetal and newborn respiratory conditions, infections, preterm delivery and low birth weight, and other birth conditions) that may be associated with high levels of bilirubin and asthma. The Asian population is at a greater risk of neonatal jaundice than the populations in other geographic regions (32) . Genetic variations such as the Gly71Arg mutation in the UGT1A1 gene are common in the Asian population, increasing the incidence of severe neonatal hyperbilirubinemia (29, 30, 32) .
Certain limitations should also be noted when interpreting our findings. In this study, we adjusted for most of the potential confounders, such as age, sex, and perinatal events (including fetal and newborn respiratory conditions, infections, preterm delivery and low birth weight, and other birth conditions), that may be associated with a high level of bilirubin and atopic diathesis. There might be some residual confounding factors, such as factors on which detailed clinical information is not included in the NHIRD (e.g., serum bilirubin level, serum IgE level, breastfeeding, and environmental exposures). In addition, estimates of the effect of the serum bilirubin level on subsequent atopic risk may have been biased. Furthermore, the study population consisted only of Chinese children; thus, our findings may not be generalizable to populations from other countries.
This study adds to the evidence of the association between neonatal jaundice and atopic diathesis. Children with neonatal jaundice are at an increased risk of several common allergic diseases; they were found to have the highest incidence rates for AR, followed by asthma, AD, and urticaria. Further research is required to clarify the pathogenesis of these associations.
METHODS

Data Sources
The NHIRD, a population-based database, is maintained by the National Health Research Institutes and is derived from the claims data of the NHI program, a mandatory-enrollment, single-payment system created in 1995 and now covering over 99% of the Taiwanese population (http://www.nhi.gov.tw/english/index.aspx) (36) . The children file (age < 18 y) was derived from the NHIRD and is maintained by the National Health Research Institutes. The children file includes the claims data of 50% children randomly selected from the pediatric population enrolled during 1996−2008 (34) (35) (36) (37) . Diseases are coded on the basis of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Because of personal electronic data privacy regulations, the information regarding the identification of insurants is encrypted before being sent to researchers. Hence, informed consent was not required for the current study. The study was approved by the Institutional Review Board of China Medical University Hospital (CMU-REC-101-012).
Study Patients
The cohort study included children with a new diagnosis of neonatal jaundice, identified according to ICD-9-CM code 774, from 2000 to 2007. The date of diagnosis of neonatal jaundice was set as the index date. Children aged >1 mo, those diagnosed with allergic disease before the index date, and those with missing information on sex or age were excluded from the study. For each child with neonatal jaundice, two children without neonatal jaundice from the same period were randomly selected and included in the nonneonatal jaundice cohort according to the aforementioned exclusion criteria. Patients with nonneonatal jaundice were frequency-matched with patients with neonatal jaundice according to sex, age, parental urbanization, parental occupation, and index date. A total of 27,693 patients with neonatal jaundice and 55,367 patients with nonneonatal jaundice were included in the current study.
Outcome Measurement and Comorbidities
Follow-up for each child in the neonatal jaundice cohort began on the first day of diagnosis of neonatal jaundice. The follow-up for each child in the nonneonatal jaundice cohort began on the matched index date. Both cohorts were followed up until the date of diagnosis of certain allergic diseases, death, withdrawal from the NHI program, or the end of 2008. To improve diagnostic reliability and to avoid the overestimation of prevalence, only children with at least one inpatient claim record Articles or two ambulatory claims in any diagnosis field with respective ICD-9-CM codes after the index date were designated as having a specific allergic disease. We identified the following atopic diseases by using ICD-9-CM codes: AC (372.05, 372.10, and 372.14), AR (477), asthma (493 and 494), AD (691), and urticaria (708.0 and 708.9). The prevalence rates of AD, AR, asthma, and urticaria in children aged 6-13 y in Taiwan in 2010 were 3.48, 26.5, 9.13, and 6.73%, respectively, according to the NHIRD (38) . Recent surveys based on questionnaires designed by the International Study of Asthma and Allergies in Childhood show similar prevalence rates of allergic diseases in children (39, 40) . In Northern Taiwan, the prevalence rates of AD, AR, and asthma in children aged 6-8 y are 10.2, 29.8, and 12.2%, respectively, and those in children aged 10-12 y are 4.7, 18.3, and 9.6%, respectively (39) . In Central Taiwan, the prevalence rates of AD, AR, and asthma in children aged 6-15 y are 3.35, 27.59, and 6.99%, respectively (40) . No significant difference in the prevalence rate was observed between the study conducted using the NHIRD and studies conducted using International Study of Asthma and Allergies in Childhood questionnaires.
Neonatal respiratory conditions, perinatal infections, preterm delivery and low birth weight, birth conditions, the male sex, low socioeconomic status, and the urban environment were considered risk factors (Table 1) for atopy. A strong association exists between preterm delivery and asthma diagnosis. In addition, many very preterm newborns develop jaundice and are treated with phototherapy (11) (12) (13) . We evaluated whether these factors influence the rates of development of five allergic diseases. When any influences were noted, the risk factors were considered confounding factors and were adjusted in subsequent study of the association between allergic diseases and neonatal jaundice. We incorporated data from inpatient and outpatient diagnosis files to ascertain comorbidities (identified according to ICD-9-CM codes), namely fetal and newborn respiratory conditions (769 and 770), infections (771), preterm delivery and low birth weight (764 and 765), other birth conditions (761-763 and 767-769), and glucose-6-phosphate dehydrogenase deficiency (282.2). Other birth conditions (classified according to ICD-9-CM codes) include fetus or newborn affected by maternal complications of pregnancy (761); fetus or newborn affected by complications pertaining to the placenta, cord, and membranes (762); fetus or newborn affected by other complications of labor and delivery (763); and birth trauma (764). The use of interventions for hyperbilirubinemia, including phototherapy and exchange transfusion, was investigated to determine the severity of neonatal jaundice.
Statistical Analysis
The demographic data of the neonatal jaundice and nonneonatal jaundice cohorts were compared using the χ 2 test. Continuous data were expressed as the mean ± SD and compared using the t-test. The Kaplan-Meier method and log-rank test were used to assess the differences in atopic event-free rates between the two cohorts. The incidence rates of atopic events were calculated for each cohort. A multivariate Cox proportional hazards model was used to calculate the HR and 95% CI of developing an atopic event associated with neonatal jaundice. This model was simultaneously adjusted for age and sex. SAS software (Version 9.2 for windows; SAS Institute, Cary, NC) was used to perform all data analyses. The Kaplan-Meier plot was created using R software (Version 2.14.1, R Development Core Team, Vienna, Austria) to estimate the cumulative hazard. All statistical tests were set at a two-tailed significance level of 0.05.
